Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas - Girmens, J F; Erginay, A; Massin, P (Am J Ophthalmol, 2003)